How a new approach to funding Alzheimer’s research could pay off
Model indicates that diverse research approaches to the disease would be a rewarding investment.
Faculty highlight: Paula Hammond
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
The Internet of medical things
Stephen Miles helps to bring the benefits of serialized identification systems to translational medicine and research.
In the cloud: How coughs and sneezes float farther than you think
Novel study uncovers the way coughs and sneezes stay airborne for long distances.
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Gruber outlines key upcoming moments in Affordable Care Act rollout
MIT expert weighs in on health plan’s status as legislation becomes reality.
Study: Having Medicaid increases emergency room visits
Unique study on Oregon’s citizens sheds light on critical care in the U.S.
New medical operations
At MIT’s ‘Innovations in Health Care’ conference, industry experts discuss how to maintain quality while reining in costs.
Doctor, doctor: Why the job market for married couples in medicine works well
New study in the growing ‘market design’ field of economics explains how a job-market algorithm helps land couples in the same locations.
Military medicine
Senior Laura Lu’s years at MIT have included cancer research, ROTC leadership, and prosthesis trials — and she aims to put her talents to use one day as a Navy surgeon.
MIT team receives $10.4 million biomanufacturing grant from DARPA
With the grant, MIT’s Biomanufacturing Research Program aims to develop new technologies that can rapidly manufacture biologic drugs on the battlefield.
The science of collaboration
The future of biomedical innovation depends in part on learning from the trend for all players to work together for the common goal, say two MIT researchers.
Nanosensors could aid drug manufacturing
Chemical engineers find that arrays of carbon nanotubes can detect flaws in drugs and help improve production.
Why tumors become drug-resistant
New findings could lead to drugs that fight back when tumors don’t respond to treatment.